Endpoints of Phase III ESSENCE trial, image source: Novo Nordisk official website These findings clearly show that semaglutide 2.4 mg not only promotes resolution of steatohepatitis but also significantly improves existing liver fibrosis, providing a powerful therapeutic option to slow or halt MASH progression
About 1 in 8 people in the United States now take a glucagon-like peptide-1, or GLP-1, medication for weight loss, diabetes, or another condition, according to a KFF poll
Dion, M
Ideal Specs: Low C-rate (1C is plenty), High energy density, small form factor (Pouch cell)
Clinical research shows that glutathione: Inhibits melanin synthesis (the skin pigment responsible for dark spots) Gently fades marks without harsh side effects A recent industry study found that up to 82% of participants noticed reduced hyperpigmentation after using a glutathione cleanser for 8 weeks
Avoid NSAIDs until you've stabilized on tirzepatide and confirmed you're not experiencing severe gastrointestinal side effects
